Joseph H Friedman

Summary

Affiliation: Brown University
Country: USA

Publications

  1. ncbi request reprint Drug-induced psychosis in Parkinson disease: phenomenology and correlations among psychosis rating instruments
    Kelvin L Chou
    Department of Clinical Neurosciences, Brown Medical School, Providence, Rhode Island, USA
    Clin Neuropharmacol 28:215-9. 2005
  2. ncbi request reprint Doctor's revenge
    Joseph H Friedman
    Med Health R I 89:296. 2006
  3. ncbi request reprint Sleep disturbances and Parkinson's disease
    Joseph H Friedman
    Neuro Health Parkinson s Disease and Movement Disorders, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA
    CNS Spectr 13:12-7. 2008
  4. doi request reprint Self perceived weakness in Parkinson's disease
    Joseph H Friedman
    Movement Disorders Program, Butler Hospital, Dept of Neurology, Alpert Medical School of Brown University, 345 Blackstone Blvd, Providence, RI 02906, USA
    Parkinsonism Relat Disord 18:887-9. 2012
  5. doi request reprint Atypical antipsychotic drugs in the treatment of Parkinson's disease
    Joseph H Friedman
    Department of Neurology, Movement Disorders Program, Butler Hospital, Alpert Medical School of Brown University, Providence, RI 02906, USA
    J Pharm Pract 24:534-40. 2011
  6. doi request reprint Clinical vignettes in Parkinson's disease: a collection of unusual medication-induced hallucinations, delusions, and compulsive behaviours
    Joseph H Friedman
    Department of Neurology, Alpert School of Medicine, Brown University, Providence, Rhode Island 02906, USA
    Int J Neurosci 121:472-6. 2011
  7. ncbi request reprint Gait in the elderly
    Joseph H Friedman
    NeuroHealth, Warwick, RI 02886, USA
    Med Health R I 91:134-5. 2008
  8. doi request reprint Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease
    Joseph H Friedman
    NeuroHealth, Parkinson s Disease and Movement Disorders Center, Warwick, Rhode Island 02886, USA
    Mov Disord 25:805-22. 2010
  9. doi request reprint Parkinson's disease psychosis 2010: a review article
    Joseph H Friedman
    Dept of Neurology, Alpert Medical School of Brown University, Butler Hospital, 345 Blackstone Blvd, Providence, RI 02906, USA
    Parkinsonism Relat Disord 16:553-60. 2010
  10. doi request reprint Rhinorrhea and olfaction in Parkinson disease
    Joseph H Friedman
    Neuro Health, 227 Centerville Rd, Warwick, RI 02886, USA
    Neurology 70:487-9. 2008

Detail Information

Publications87

  1. ncbi request reprint Drug-induced psychosis in Parkinson disease: phenomenology and correlations among psychosis rating instruments
    Kelvin L Chou
    Department of Clinical Neurosciences, Brown Medical School, Providence, Rhode Island, USA
    Clin Neuropharmacol 28:215-9. 2005
    ....
  2. ncbi request reprint Doctor's revenge
    Joseph H Friedman
    Med Health R I 89:296. 2006
  3. ncbi request reprint Sleep disturbances and Parkinson's disease
    Joseph H Friedman
    Neuro Health Parkinson s Disease and Movement Disorders, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA
    CNS Spectr 13:12-7. 2008
    ..Treatment plans for patients with Parkinson's disease who experience sleep disorders aim to improve nighttime sleep or daytime wakefulness, and treatment options vary by sleep disorder...
  4. doi request reprint Self perceived weakness in Parkinson's disease
    Joseph H Friedman
    Movement Disorders Program, Butler Hospital, Dept of Neurology, Alpert Medical School of Brown University, 345 Blackstone Blvd, Providence, RI 02906, USA
    Parkinsonism Relat Disord 18:887-9. 2012
    ..Relative weakness, and early muscle fatigue may be demonstrated on testing but frank weakness should not be apparent on routine clinical examination...
  5. doi request reprint Atypical antipsychotic drugs in the treatment of Parkinson's disease
    Joseph H Friedman
    Department of Neurology, Movement Disorders Program, Butler Hospital, Alpert Medical School of Brown University, Providence, RI 02906, USA
    J Pharm Pract 24:534-40. 2011
    ..The other atypical have been the subjects of conflicting open label reports. The effects of the atypicals in PD psychosis is reviewed...
  6. doi request reprint Clinical vignettes in Parkinson's disease: a collection of unusual medication-induced hallucinations, delusions, and compulsive behaviours
    Joseph H Friedman
    Department of Neurology, Alpert School of Medicine, Brown University, Providence, Rhode Island 02906, USA
    Int J Neurosci 121:472-6. 2011
    ..This report is a compilation of vignettes describing these behavioral problems that the treating neurologist or psychiatrist attributed to the medications used for treating PD...
  7. ncbi request reprint Gait in the elderly
    Joseph H Friedman
    NeuroHealth, Warwick, RI 02886, USA
    Med Health R I 91:134-5. 2008
  8. doi request reprint Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease
    Joseph H Friedman
    NeuroHealth, Parkinson s Disease and Movement Disorders Center, Warwick, Rhode Island 02886, USA
    Mov Disord 25:805-22. 2010
    ..The committee concluded that current scales are adequate for fatigue studies in PD but that studies on sensitivity and specificity of the scales are still needed...
  9. doi request reprint Parkinson's disease psychosis 2010: a review article
    Joseph H Friedman
    Dept of Neurology, Alpert Medical School of Brown University, Butler Hospital, 345 Blackstone Blvd, Providence, RI 02906, USA
    Parkinsonism Relat Disord 16:553-60. 2010
    ..Only clozapine has level I evidence to support its use. Quetiapine is the only other anti-psychotic free of motor side effects, but it has failed double blind placebo controlled trials to demonstrate efficacy...
  10. doi request reprint Rhinorrhea and olfaction in Parkinson disease
    Joseph H Friedman
    Neuro Health, 227 Centerville Rd, Warwick, RI 02886, USA
    Neurology 70:487-9. 2008
  11. ncbi request reprint Rhinorrhea is increased in Parkinson's disease
    Joseph H Friedman
    Parkinson s Disease and Movement Disorders Center of NeuroHealth, Warwick, Rhode Island 02886, USA
    Mov Disord 23:452-4. 2008
    ..These observations confirm that rhinorrhea is a common problem and raise the questions as to whether some olfactory impairment found in PD could be confounded by rhinorrhea and also whether rhinorrhea may be a premotor symptom...
  12. doi request reprint Managing idiopathic Parkinson's disease in patients with schizophrenic disorders
    Joseph H Friedman
    Movement Disorders Program, Butler Hospital, 345 Blackstone Blvd, Providence, RI 02903, USA
    Parkinsonism Relat Disord 17:198-200. 2011
    ..None of the patients suffered worsened psychosis from l-Dopa or a dopamine agonist if taking antipsychotics, and motor response did not appear blunted...
  13. doi request reprint Neuropsychiatric disorders: What do neurologists think about conversion disorder?
    Joseph H Friedman
    Program in Movement Disorders, Butler Hospital, 345 Blackstone Boulevard, Providence, RI 02906, USA
    Nat Rev Neurol 7:306-7. 2011
    ..Instead, the results indicate that the neurologist’s diagnosis is influenced largely by their communication with the patients...
  14. doi request reprint Fatigue in Parkinson's disease
    Joseph H Friedman
    Movement Disorders Program, Butler Hospital, 345 Blackstone Blvd, Providence, RI 02906, USA
    Expert Opin Pharmacother 12:1999-2007. 2011
    ..Research on fatigue has focused on its epidemiology with only a single report of a beneficial treatment trial, which used methylphenidate...
  15. ncbi request reprint Fatigue in Parkinson's disease: a review
    Joseph H Friedman
    NeuroHealth, Warwick, Rhode Island 02886, USA
    Mov Disord 22:297-308. 2007
    ..This article reviews what is known about the symptom, putting it into the context of fatigue in other disorders, and outlines a program for developing better understanding and therapy...
  16. ncbi request reprint Atypical antipsychotics in the elderly with Parkinson disease and the "black box" warning
    Joseph H Friedman
    NeuroHealth Parkinson s Disease and Movement Disorders Center, 227 Centerville Rd, Warwick, RI 02886, USA
    Neurology 67:564-6. 2006
    ..In this article, the author reviews the history of these developments and raises issues that still need to be addressed by the neurologic community...
  17. ncbi request reprint Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease
    Joseph H Friedman
    Parkinson Disease and Movement Disorders Center, NeuroHealth, Warwick, Rhode Island 02886, USA
    Mov Disord 21:2078-81. 2006
    ..While some patients had a favorable response, aripiprazole was associated with an exacerbation of motor symptoms. In this small study on psychosis in PD, aripiprazole did not appear promising...
  18. ncbi request reprint Fatigue in Parkinson's disease patients
    Joseph H Friedman
    Joseph H Friedman, MD Parkinson s Disease and Movement Disorders Center, NeuroHealth, 227 Centerville Road, Warwick, RI 02886, USA
    Curr Treat Options Neurol 11:186-90. 2009
    ..Some patients may take their doses unevenly, with more or less for the morning dose. Patients who tend to go to bed late at night may take their doses three times daily...
  19. pmc Neuropsychological Profile of Parkin Mutation Carriers with and without Parkinson Disease: The CORE-PD Study
    Elise Caccappolo
    Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, New York, USA
    J Int Neuropsychol Soc 17:91-100. 2011
    ..Carriers of parkin mutations, whether or not they have PD, do not perform differently on neuropsychological measures as compared to noncarriers. The cognitive functioning of parkin carriers over time warrants further study...
  20. pmc Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study
    Roy N Alcalay
    Department of Neurology, Columbia University, New York, NY 10032, USA
    Arch Neurol 67:1116-22. 2010
    ..To assess the frequency and clinical characteristics of carriers of previously identified mutations in 6 genes associated with early-onset Parkinson disease (PD) and provide empirical data that can be used to inform genetic counseling...
  21. pmc Self-report of cognitive impairment and mini-mental state examination performance in PRKN, LRRK2, and GBA carriers with early onset Parkinson's disease
    Roy N Alcalay
    Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, NY, USA
    J Clin Exp Neuropsychol 32:775-9. 2010
    ..GBA carriers reported more impairment, but MMSE performance did not differ among genetic groups. Detailed neuropsychological testing is required to explore the association between cognitive impairment and GBA mutations...
  22. doi request reprint Scales to assess psychosis in Parkinson's disease: Critique and recommendations
    Hubert H Fernandez
    Department of Neurology, McKnight Brain Institute University of Florida, Gainesville, Florida 32611, USA
    Mov Disord 23:484-500. 2008
    ..The CGIS is suggested as a secondary outcome scale to measure change and response to treatment over time...
  23. ncbi request reprint Long-term outcome of quetiapine use for psychosis among Parkinsonian patients
    Hubert H Fernandez
    Department of Clinical Neurosciences, Brown University School of Medicine, Providence, Rhode Island, USA
    Mov Disord 18:510-4. 2003
    ..6; 95% CI = 1.4-92.9). Also, patients who developed motor worsening while on quetiapine tended to be more demented (P = 0.07)...
  24. ncbi request reprint Atypical antipsychotics in Parkinson-sensitive populations
    Joseph H Friedman
    Department of Clinical Neurosciences, Brown University School of Medicine, Providence, Rhode Island, USA
    J Geriatr Psychiatry Neurol 15:156-70. 2002
    ..Suggestions are made for future research to improve the interpretability of these studies...
  25. doi request reprint Falls and the falls efficacy scale in Parkinson's disease
    Alissa A Thomas
    Department of Neurology, Dartmouth Hitchcock Medical Center, Warren Alpert Medical School of Brown University, Hanover, NH, USA
    J Neurol 257:1124-8. 2010
    ..The lack of fear of falling but frequent falls in this small subgroup may suggest that special techniques to instill suitable caution to prevent falls are necessary, or may make training of these patients impossible...
  26. ncbi request reprint The management of psychosis in movement disorder patients
    Kelvin L Chou
    Department of Clinical Neurosciences, Warren Alpert Medical School of Brown University, Providence, RI, USA
    Expert Opin Pharmacother 8:935-43. 2007
    ..This review covers the management of psychosis in three different movement disorders: Parkinson's disease, dementia with Lewy bodies and Huntington's disease...
  27. ncbi request reprint Phenomenology of dreams in Parkinson's disease
    Leora L Borek
    NeuroHealth Parkinson s Disease and Movement Disorders Center, Warwick, Rhode Island, USA
    Mov Disord 22:198-202. 2007
    ..Men with PD had more aggressive dreams compared to females with PD. Aggressive dream content was characteristic of RBD patients and sex differences exist in the dream content of the PD population...
  28. ncbi request reprint Testosterone not associated with violent dreams or REM sleep behavior disorder in men with Parkinson's
    Kelvin L Chou
    NeuroHealth Parkinson s Disease and Movement Disorders Center, Warwick, Rhode Island 02886, USA
    Mov Disord 22:411-4. 2007
    ..While dream content appears to be more aggressive in PD patients with clinical RBD, the presence of violent dreams or clinical RBD is not associated with testosterone levels in men with PD...
  29. ncbi request reprint Non-motor aspects of Parkinson's disease
    Leora L Borek
    Department of Geriatric Psychiatry, Brown University School of Medicine, Providence, RI, USA
    CNS Spectr 11:541-54. 2006
    ..The phenomenology, pathology, and treatment of the behavioral symptoms of Parkinson's disease will be discussed...
  30. ncbi request reprint Management of the behavioral aspects of Parkinson's disease
    Leora L Borek
    Neurohealth Alzheimer s Disease and Movement Disorders Center, and Department of Geriatric Psychiatry, Butler Hospital, Warren Alpert Medical School of Brown University, RI, USA
    Expert Rev Neurother 7:711-25. 2007
    ..This review focuses on the management of the most common behavioral symptoms of Parkinson's disease, including depression, anxiety, psychosis, dementia, delirium, sleep disorders, fatigue, apathy, emotionalism and compulsive behaviors...
  31. doi request reprint Physical activity and neuropsychiatric symptoms of Parkinson disease
    Ana M Abrantes
    Butler Hospital, Providence, RI 02906, USA
    J Geriatr Psychiatry Neurol 25:138-45. 2012
    ..Developing and tailoring exercise programs that incorporate specific preferences may result in more effective interventions for patients with PD...
  32. ncbi request reprint A comparison of fatigue measures in Parkinson's disease
    Janet Grace
    Department of Psychiatry and Human Behavior, Brown Medical School, Providence, RI, USA
    Parkinsonism Relat Disord 13:443-5. 2007
    ..PD patients and healthy controls differed significantly on both measures. PD patients endorsed significantly more fatigue. The PFS is a reliable, valid fatigue measure...
  33. ncbi request reprint Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group
    Bernard Ravina
    Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, NY 14620, USA
    Mov Disord 22:1061-8. 2007
    ..These criteria require validation and may be refined, but form a starting point for studies of the epidemiology and pathophysiology of PDPsy, and are a potential indication for therapy development...
  34. ncbi request reprint Diabetes mellitus among parkinsonian patients treated chronically with clozapine
    Hubert H Fernandez
    Department of Neurology, University of Florida, Gainesville, FL, USA
    Parkinsonism Relat Disord 10:439-41. 2004
    ..3% for ages > or = 60 years). In this small study, parkinsonian patients on long-term, low dose clozapine were not at increased risk for developing DM. Larger controlled prospective studies are needed to confirm this...
  35. ncbi request reprint Quetiapine for psychosis in Parkinson's disease versus dementia with Lewy bodies
    Hubert H Fernandez
    Department of Clinical Neurosciences, Brown University School of Medicine, Providence, RI, USA
    J Clin Psychiatry 63:513-5. 2002
    ..Most clinicians perceive psychosis in dementia with Lewy bodies (DLB) as more difficult to treat than Parkinson's disease, yet there are no reports comparing the antipsychotic response between the 2 disorders...
  36. ncbi request reprint Treatment of psychosis in Parkinson's disease: safety considerations
    Hubert H Fernandez
    Department of Clinical Neurosciences, Brown University School of Medicine, Providence, Rhode Island, USA
    Drug Saf 26:643-59. 2003
    ..Electroconvulsive treatment is generally reserved for the patient with psychotic depression who is unable to tolerate any pharmacological therapy...
  37. ncbi request reprint Botulinum toxin type B for gait freezing in Parkinson's disease
    Hubert H Fernandez
    Department of Clinical Neuroscience, Brown University School of Medicine, Providence, RI, USA
    Med Sci Monit 10:CR282-4. 2004
    ..Freezing of Gait (FOG) can be a serious problem in Parkinson's disease (PD) and is usually refractory to medical treatment. Botulinum toxin (BTX) type A has been reported to relieve FOG in small open label studies...
  38. ncbi request reprint Long-term outcome of clozapine use for psychosis in parkinsonian patients
    Hubert H Fernandez
    Department of Clinical Neurosciences, Brown Uniersity School of Medicine, Providence, Rhode Island, USA
    Mov Disord 19:831-3. 2004
    ..Our data are more consistent with recently published long-term outcome data suggesting an improvement in the prognosis of parkinsonian patients with psychosis with the use of atypical antipsychotic agents such as clozapine...
  39. ncbi request reprint Hemiballismus from a parietal stroke in a Parkinson patient
    Motasem Al-Yacoub
    Department of Clinical Neurosciences, Brown University School of Medicine, Providence, RI, USA
    Mov Disord 19:986-8. 2004
    ..This suggests that HB itself, whether from a lesion in the subthalamic nucleus or elsewhere, is not what improves motor function in PD; instead, the physiological function of the damaged structure is the determining factor...
  40. doi request reprint Olfaction and apathy in Parkinson's disease
    Christina K Cramer
    The Alpert Medical School at Brown University, 343 Lloyd ave, Providence, RI 02906, USA
    Parkinsonism Relat Disord 16:124-6. 2010
    ..However, no study until this point has been published investigating whether there is any association between olfactory dysfunction and apathy in PD patients...
  41. ncbi request reprint Levodopa addiction in idiopathic Parkinson disease
    Leora L Borek
    Department of Neurology, Memorial Hospital, Brown University, Providence, RI, USA
    Neurology 65:1508. 2005
  42. ncbi request reprint Are atypical antipsychotics associated with a reduced risk of developing parkinsonism?
    Kelvin L Chou
    Department of Clinical Neurosciences, Brown University, Providence, RI, USA
    Nat Clin Pract Neurol 2:132-3. 2006
  43. ncbi request reprint Cognitive and behavioral features discriminate between Alzheimer's and Parkinson's disease
    Deborah A Cahn-Weiner
    Memorial Hospital of Rhode Island and Brown Medical School, Pawtucket 02860, USA
    Neuropsychiatry Neuropsychol Behav Neurol 15:79-87. 2002
    ..To compare the cognitive and behavioral profiles of Alzheimer's disease (AD) and cognitively impaired patients with Parkinson's disease (PD) and to determine the individual measures that best discriminate the two patient groups...
  44. ncbi request reprint Presumed rapid eye movement behavior disorder in Machado-Joseph disease (spinocerebellar ataxia type 3)
    Joseph H Friedman
    Department of Clinical Neurosciences, Brown University Medical School, Providence, Rhode Island 02860, USA
    Mov Disord 17:1350-3. 2002
    ..Polysomnography was normal in 1 patient. Two of these patients had had single photon emission computed tomographic imaging of the dopamine transporter 1 year previously...
  45. pmc Reduction of freezing of gait in Parkinson's disease by repetitive robot-assisted treadmill training: a pilot study
    Albert C Lo
    VA RR and D Center of Excellence Center for Restorative and Regenerative Medicine, Providence VA Medical Center, 830 Chalkstone Ave, Providence, RI 02908, USA
    J Neuroeng Rehabil 7:51. 2010
    ..The purpose of this study was to examine the potential effect of continuous physical cueing using robot-assisted sensorimotor gait training on reducing FOG episodes and improving gait...
  46. ncbi request reprint REM behavior disorder and excessive daytime somnolence in Machado-Joseph disease (SCA-3)
    Joseph H Friedman
    Department of Clinical Neurosciences, Brown University School of Medicine, Providence, Rhode Island 02860, USA
    Mov Disord 18:1520-2. 2003
    ..Our results support the previous observation that RBD-like behaviors are significantly increased in SCA-3...
  47. doi request reprint Current use of clozapine in Parkinson disease and related disorders
    Alissa A Thomas
    Alpert Medical School, Brown University, Providence, RI 02886, USA
    Clin Neuropharmacol 33:14-6. 2010
    ..Clozapine has been shown to be effective in the treatment of Parkinson disease psychosis and tremor; however, use of clozapine has been limited because of potential adverse effects and stringent monitoring criteria...
  48. ncbi request reprint Classification and treatment of tardive syndromes
    Hubert H Fernandez
    Department of Clinical Neurosciences, Brown University School of Medicine, Providence, Rhode Island, USA
    Neurologist 9:16-27. 2003
    ..Tardive syndromes are a group of delayed-onset abnormal involuntary movement disorders induced by a dopamine receptor blocking agent. There are several phenomenologically distinct types of TS...
  49. doi request reprint Letter to the editor: successful use of electroconvulsive therapy for refractory anxiety in Parkinson's disease
    Louis Marino
    Dept of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Butler Hospital, Providence, Rhode Island 02906, USA
    Int J Neurosci 123:70-1. 2013
    ..This report describes two patient with idiopathic PD and severe anxiety who responded well to ECT. ECT should be considered for PD patients with severe behavioral problems not responsive to medications...
  50. ncbi request reprint Tardive syndromes in the elderly
    Kelvin L Chou
    Department of Clinical Neurosciences, Brown Medical School, 227 Centerville Road, Warwick, RI 02886, USA
    Clin Geriatr Med 22:915-33, viii. 2006
    ..This article summarizes the clinical phenomenology, pathophysiology, epidemiology, and treatment of these disorders in elderly individuals...
  51. ncbi request reprint Dextromethorphan-induced neurologic illness in a patient with negative toxicology findings
    Joseph K Cherkes
    Department of Toxicology, Rhode Island Hospital, Providence, USA
    Neurology 66:1952-3. 2006
  52. ncbi request reprint Monozygotic twins discordant for Huntington disease after 7 years
    Joseph H Friedman
    Department of Clinical Neurosciences, Brown University School of Medicine, Providence, RI, USA
    Arch Neurol 62:995-7. 2005
    ..Huntington disease (HD) has only rarely been identified in identical twins. All described twins have had disease onset within 1 year of each other, suggesting that disease onset is determined solely by genetic influences...
  53. doi request reprint Hospitalization in Parkinson disease: a survey of National Parkinson Foundation Centers
    Kelvin L Chou
    Department of Neurology, University of Michigan, Ann Arbor, MI 48109 5316, USA
    Parkinsonism Relat Disord 17:440-5. 2011
    ..To explore current practices and opinions regarding hospital management of Parkinson disease (PD) patients in specialized PD Centers...
  54. doi request reprint The Glabellar reflex is a poor measure of Parkinson motor severity
    Joseph H Friedman
    Movement Disorders Program of Butler Hospital and Department of Neurology, Alpert Medical School of Brown University, Providence, RI, USA Joseph
    Int J Neurosci 123:417-9. 2013
    ..It is one of ten items used in the Simpson Angus Scale, a popular measure of parkinsonism in psychiatric studies of neuroleptic drugs. We hypothesized that the GR might be a measure of hypomimia...
  55. ncbi request reprint Executive and emotional dysfunction in Machado-Joseph disease
    Tricia M Zawacki
    Department of Psychiatry and Human Behavior, Brown University School of Medicine, Providence, Rhode Island 02903, USA
    Mov Disord 17:1004-10. 2002
    ..Impaired executive abilities and emotional functioning in MJD patients is consistent with disruption of frontal-subcortical systems...
  56. pmc Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson disease
    Roy N Alcalay
    Department of Neurology, Columbia University, New York, NY 10032, USA
    Arch Neurol 66:1517-22. 2009
    ....
  57. ncbi request reprint Neurodegenerative disorders mimicking progressive supranuclear palsy: a report of three cases
    Marjorie A Murphy
    Department of Ophthalmology, Rhode Island Hospital, Brown Medical School MAM, RI 02903, USA
    J Clin Neurosci 12:941-5. 2005
    ..We describe three cases diagnosed during life as PSP but found to have another neurologic disorder at autopsy. No explanation for the gaze palsies was found in any case...
  58. ncbi request reprint Historical perspective on movement disorders
    Joseph H Friedman
    Brown University Medical School and the Division of Neurology, Memorial Hospital of Rhode Island, Pawtucket, RI 02860, USA
    J Clin Psychiatry 65:3-8. 2004
    ..With the development of the atypical antipsychotics, the incidence and prevalence of tardive dyskinesia have dropped remarkably, suggesting that psychosis, its treatment, and dyskinesias are not inextricably linked...
  59. ncbi request reprint Effects of fatigue on physical activity and function in patients with Parkinson's disease
    Carol Ewing Garber
    Bouve College of Health Sciences, Department of Cardiopulmonary and Exercise Sciences, Northeastern University, Boston, MA 02115, USA
    Neurology 60:1119-24. 2003
    ..To characterize the relationships between symptoms of fatigue, physical activity, physical function, and functional capacity in patients with idiopathic PD...
  60. ncbi request reprint Re: Klintenberg et al, tardive dyskinesia model in the common marmoset
    Joseph H Friedman
    Mov Disord 18:114-5. 2003
  61. ncbi request reprint Aripiprazole for drug-induced psychosis in Parkinson disease: preliminary experience
    Hubert H Fernandez
    Department of Neurology, University of Florida College of Medicine, Gainesville, FL 32610
    Clin Neuropharmacol 27:4-5. 2004
    ..Our preliminary experience with aripiprazole is mixed but not very encouraging. Controlled studies are needed to evaluate aripiprazole in parkinsonian patients...
  62. ncbi request reprint Iatrogenesis imperfecta
    Joseph H Friedman
    Med Health R I 85:198. 2002
  63. ncbi request reprint Risperidone and Parkinson's disease
    Stewart A Factor
    Mov Disord 17:221-2. 2002
  64. ncbi request reprint Parkinsonism in a nursing home: underrecognition
    Joseph H Friedman
    Division of Neurology, Memorial Hospital of Rhode Island, 111 Brewster St, Pawtucket, RI 02860, USA
    J Geriatr Psychiatry Neurol 17:39-41. 2004
    ..02). Only 1 patient with drug-induced parkinsonism and 3 residents with previously diagnosed Parkinson's disease had chart notes indicating that parkinsonism had been recognized...
  65. ncbi request reprint Mood and sleep in Parkinson's disease
    Leora L Borek
    Department of Psychiatry and Human Behavior, Butler Hospital
    J Clin Psychiatry 67:958-63. 2006
    ..To determine whether severity of depression and severity of anxiety were associated with particular types of sleep disturbance in patients with Parkinson's disease...
  66. ncbi request reprint Anticholinergics in dementia and other confounding problems
    Joseph H Friedman
    Am J Geriatr Psychiatry 14:384; author reply 384-5. 2006
  67. ncbi request reprint Olanzapine in the treatment of dopamimetic-induced psychosis in patients with Parkinson's disease
    Alan Breier
    Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA
    Biol Psychiatry 52:438-45. 2002
    ..We report results from two placebo-controlled, double-blind studies of olanzapine for treatment of dopamimetic drug-induced psychosis in patients with Parkinson's disease (PD)...
  68. ncbi request reprint Dreams in neurological diseases
    Joseph H Friedman
    Med Health R I 89:388. 2006
  69. ncbi request reprint "... But I can still sue you, can't I"?
    Joseph H Friedman
    Med Health R I 90:170. 2007
  70. ncbi request reprint Ophthalmologic features of Parkinson's disease
    Joseph H Friedman
    Neurology 63:940-1; author reply 940-1. 2004
  71. ncbi request reprint Predictors of deterioration in health-related quality of life in Parkinson's disease: results from the DATATOP trial
    Connie Marras
    Division of Neurology, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada
    Mov Disord 23:653-9; quiz 776. 2008
    ..Our focus in clinical care needs to be broadened beyond assessing and treating Parkinsonism, recognizing the impact of mood, cognition and function on HRQOL...
  72. ncbi request reprint Genetic markers and the majority's right not to know
    Jacob Appel
    Mov Disord 19:113-4. 2004
  73. ncbi request reprint Re: Atypical antipsychotics mechanisms of action
    Joseph H Friedman
    Can J Psychiatry 48:62; author reply 62-4. 2003
  74. ncbi request reprint Neuroprotective trials: no longer a cautious optimism
    Joseph H Friedman
    Med Health R I 91:158. 2008
  75. ncbi request reprint Missed opportunities, missing opportunities and clinical creativity
    Joseph H Friedman
    Med Health R I 88:176. 2005
  76. ncbi request reprint Atypical antipsychotics have very different adverse effect profiles and should not be lumped together
    Joseph H Friedman
    Arch Intern Med 166:586; author reply 586-7. 2006
  77. ncbi request reprint Folie a deux
    Joseph H Friedman
    Med Health R I 87:2-3. 2004
  78. ncbi request reprint Needless tests
    Joseph H Friedman
    Med Health R I 85:262-3. 2002
  79. ncbi request reprint More on repetitive behaviors in Parkinson's disease
    Joseph H Friedman
    Mov Disord 20:509; author reply 509-10. 2005
  80. ncbi request reprint Randomized, double-blind, placebo-controlled trials: the gold standard?
    Joseph H Friedman
    Med Health R I 87:262-3. 2004
  81. ncbi request reprint Conventional or atypical antipsychotics and the risk of femur fracture among elderly patients: results of a case-control study
    Rosa Liperoti
    Center for Medicine of Aging, Department of Gerontology and Geriatrics, Catholic University of the Sacred Heart, Rome, Italy
    J Clin Psychiatry 68:929-34. 2007
    ..The aim of this study was to estimate the effect of atypical and conventional antipsychotics on the risk of hospitalization for femur fracture...
  82. ncbi request reprint Gratification
    Joseph H Friedman
    Med Health R I 86:374. 2003
  83. ncbi request reprint A good result isn't always a good result
    Joseph H Friedman
    Med Health R I 90:202. 2007
  84. ncbi request reprint Chronic pain in Machado-Joseph disease: a frequent and disabling symptom
    Marcondes C Franca
    Department of Neurology, Universidade Estadual de Campinas UNICAMP, Rua Tessália Vieira de Camargo, 126 Cidade Universitaria Zeferino Vaz, Campinas, SP, Brazil
    Arch Neurol 64:1767-70. 2007
    ..Although patients frequently report pain, systematic evaluation of this clinical feature is lacking...
  85. ncbi request reprint Rating instruments
    Joseph H Friedman
    Med Health R I 91:2-3. 2008
  86. ncbi request reprint Sleep and fatigue in Parkinson's disease
    Joseph H Friedman
    Division of Neurology, Memorial Hospital of Rhode Island, Pawtucket, RI 02860, USA
    Parkinsonism Relat Disord 10:S27-35. 2004
    ..An overview of sleep disorders in PD and an approach to therapy will also be outlined. The little that is known about fatigue in PD will be reviewed...
  87. ncbi request reprint Introduction to geriatric neurology issue
    Joseph H Friedman
    Med Health R I 91:126. 2008